Emily E. Truong - Publications

Multiparametric magnetic resonance imaging may improve detection of patients with at-risk MASH: Real world experience in hepatology clinics.

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Published: February 04, 2025

Letter to the Editor: Serum identification of at-risk MASH: The metabolomics-advanced steatohepatitis fibrosis score (MASEF).

Journal: Hepatology (Baltimore, Md.)

Published: June 13, 2024

Agile 3+ and 4 Scores Accurately Predict Major Adverse Liver Outcomes, Liver Transplant, Progression of MELD Score, the Development of Hepatocellular Carcinoma, and Death in NAFLD.

Journal: Digestive diseases and sciences

Published: May 18, 2024

Excess non-COVID-19-related mortality among inflammatory bowel disease decedents during the COVID-19 pandemic.

Journal: World journal of gastroenterology

Published: November 20, 2023

Type 2 diabetes, hepatic decompensation, and hepatocellular carcinoma in patients with non-alcoholic fatty liver disease: an individual participant-level data meta-analysis.

Journal: The lancet. Gastroenterology & hepatology

Published: April 11, 2023

Performance of non-invasive tests and histology for the prediction of clinical outcomes in patients with non-alcoholic fatty liver disease: an individual participant data meta-analysis.

Journal: The lancet. Gastroenterology & hepatology

Published: March 08, 2023

Diagnostic accuracy of non-invasive tests to screen for at-risk MASH-An individual participant data meta-analysis.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: March 03, 2023

Magnetic resonance elastography-based prediction model for hepatic decompensation in NAFLD: A multicenter cohort study.

Journal: Hepatology (Baltimore, Md.)

Published: January 20, 2023

Reply: Machine learning models for NAFLD/NASH and cirrhosis diagnosis and staging: accuracy and routine variables are the success keys.

Journal: Hepatology (Baltimore, Md.)

Published: November 23, 2022

MRI-AST (MAST) Score Accurately Predicts Major Adverse Liver Outcome, Hepatocellular Carcinoma, Liver Transplant, and Liver-Related Death.

Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Published: September 22, 2022

Serum identification of at-risk MASH: The metabolomics-advanced steatohepatitis fibrosis score (MASEF).

Journal: Hepatology (Baltimore, Md.)

Published: July 08, 2022

Nonalcoholic Steatohepatitis Drug Development Pipeline: An Update.

Journal: Seminars in liver disease

Published: June 16, 2022